Anticoagulation After Thrombolysis for STEMI
Anticoagulation should be started immediately with the thrombolytic agent, not hours afterward—it is administered concurrently as adjunctive therapy and continued for a minimum of 48 hours, preferably until hospital discharge (up to 8 days) or revascularization. 1
Timing and Administration
The question appears to reflect a misunderstanding about anticoagulation timing in STEMI thrombolysis. Anticoagulation is not delayed after fibrinolytic therapy—it is given as part of the initial reperfusion strategy. The 2013 ACC/AHA guidelines explicitly state that patients undergoing fibrinolytic therapy should receive anticoagulant therapy for a minimum of 48 hours and preferably for the duration of hospitalization, up to 8 days or until revascularization 1, 2. This is a Class I, Level of Evidence A recommendation.
Specific Anticoagulation Regimens
Three anticoagulation options are recommended 1, 3:
Unfractionated Heparin (UFH)
- IV bolus of 60 U/kg (maximum 4000 U)
- Followed by 12 U/kg/h infusion (maximum 1000 U initially)
- Adjusted to maintain aPTT 1.5-2.0 times control (approximately 50-70 seconds)
- Duration: 48 hours or until revascularization
Enoxaparin (Preferred over UFH)
- Age <75 years: 30 mg IV bolus, then 15 minutes later start 1 mg/kg subcutaneously every 12 hours (maximum 100 mg for first 2 doses)
- Age ≥75 years: No bolus, 0.75 mg/kg subcutaneously every 12 hours (maximum 75 mg for first 2 doses)
- CrCl <30 mL/min: 1 mg/kg subcutaneously every 24 hours regardless of age
- Duration: Index hospitalization, up to 8 days or until revascularization
Fondaparinux
- Initial dose 2.5 mg IV, then 2.5 mg subcutaneously daily starting the following day
- Duration: Index hospitalization, up to 8 days or until revascularization
- Contraindicated if CrCl <30 mL/min
Critical Timing Considerations
If PCI is planned after successful fibrinolysis, the 2013 ACC/AHA and 2017 ESC guidelines recommend 3, 4:
- Angiography should NOT be performed within the first 2-3 hours after fibrinolytic administration
- Optimal timing is 3-24 hours after successful fibrinolysis (Class IIa, Level B) 3, 4
- Immediate transfer is indicated for cardiogenic shock, severe heart failure, or failed reperfusion 3
When continuing anticoagulation through PCI 3:
- UFH: Continue through PCI with additional IV boluses to maintain therapeutic ACT
- Enoxaparin: No additional drug if last dose within 8 hours; give 0.3 mg/kg IV bolus if last dose 8-12 hours earlier
- Fondaparinux: Class III Harm as sole anticoagulant for PCI—requires additional anticoagulation
Common Pitfalls
- Do not delay anticoagulation—it must be given with or immediately after the fibrinolytic agent, not hours later
- Do not stop anticoagulation prematurely—maintain for minimum 48 hours, preferably until discharge or revascularization
- Do not use fondaparinux alone during PCI—it requires supplemental anticoagulation with UFH or bivalirudin
- Adjust enoxaparin dosing for age ≥75 years and renal dysfunction to prevent bleeding complications
The 2025 ACC/AHA guidelines 5 reaffirm these principles, emphasizing that fibrinolytic therapy with adjunctive anticoagulation should be administered when anticipated delay to primary PCI exceeds 120 minutes from first medical contact.